Novo Nordisk A/S (NVO)
Novo Nordisk A/S Max Pain By Strike
NVO trades at $52.44, 4.9% above the near-term max pain of $50 expiring Aug 22, 2025 (6 days). Price stability likely with balanced options positioning at this level. Max pain is falling across expirations ($45-$65), signaling increased put positioning or downside protection. Key magnetic zone at 55 where 5 expirations converge.
Novo Nordisk A/S Max Pain By Expiry
Max pain for NVO shows a downward trend from 65 to 45, indicating bearish sentiment or hedging activity. The 37% spread signals divergent expectations across timeframes. Levels distributed around 52.44. Strong magnetic level at 55 (5 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 22, 2025 | 50 | -2.44 (-4.65%) |
| Aug 29, 2025 | 50 | -2.44 (-4.65%) |
| Sep 5, 2025 | 50 | -2.44 (-4.65%) |
| Sep 12, 2025 | 48 | -4.44 (-8.47%) |
| Sep 19, 2025 | 60 | 7.56 (14.42%) |
| Sep 26, 2025 | 50 | -2.44 (-4.65%) |
| Oct 17, 2025 | 55 | 2.56 (4.88%) |
| Nov 21, 2025 | 55 | 2.56 (4.88%) |
| Dec 19, 2025 | 60 | 7.56 (14.42%) |
| Jan 16, 2026 | 65 | 12.56 (23.95%) |
| Mar 20, 2026 | 55 | 2.56 (4.88%) |
| Jun 18, 2026 | 55 | 2.56 (4.88%) |
| Sep 18, 2026 | 55 | 2.56 (4.88%) |
| Jan 15, 2027 | 60 | 7.56 (14.42%) |
| Dec 17, 2027 | 45 | -7.44 (-14.19%) |